Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system

被引：451

作者：

Palmer, BF ^{[1
]}

机构：

[1] Univ Texas, SW Med Sch, Dept Med, Div Nephrol, Dallas, TX 75390 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 351卷 / 06期

关键词：

D O I：

10.1056/NEJMra035279

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：585 / 592

页数：8

共 59 条

[41] Drug-induced hyperkalemia [J].

Pantanowitz, L .

AMERICAN JOURNAL OF MEDICINE, 2002, 112 (04) :334-334

[42]

Perazella M A, 1997, Am J Ther, V4, P343, DOI 10.1097/00045391-199709000-00010

[43] Drug-induced hyperkalemia: Old culprits and new offenders [J].

Perazella, MA .

AMERICAN JOURNAL OF MEDICINE, 2000, 109 (04) :307-314

[44] Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both [J].

Pfeffer, MA ;

McMurray, JJV ;

Velazquez, EJ ;

Rouleau, JL ;

Kober, L ;

Maggioni, AP ;

Solomon, SD ;

Swedberg, K ;

Van de Werf, F ;

White, H ;

Leimberger, JD ;

Henis, M ;

Edwards, S ;

Zelenkofske, S ;

Sellers, MA ;

Califf, RM ;

Aylward, P ;

Armstrong, P ;

Barvik, S ;

Belenkov, Y ;

Dalby, A ;

Diaz, R ;

Drexler, H ;

Ertl, G ;

Francis, G ;

Hampton, J ;

Harsanyi, A ;

Kvasnicka, J ;

Mareev, V ;

Marin-Neto, J ;

Murin, J ;

Myers, M ;

Nordlander, R ;

Opolski, G ;

Soler-Soler, J ;

Spac, J ;

Stefenelli, T ;

Sugrue, D ;

Van Gilst, W ;

Varshavsky, S ;

Weaver, D ;

Zannad, F ;

Aguilar, D ;

Alvarez, A ;

Al-Taweel, M ;

Anavekar, N ;

Finn, P ;

Lopez-Jimenez, F ;

Mercier, R ;

Lewis, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20) :1893-1906

[45] Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [J].

Pitt, B ;

Remme, W ;

Zannad, F ;

Neaton, J ;

Martinez, F ;

Roniker, B ;

Bittman, R ;

Hurley, S ;

Kleiman, J ;

Gatlin, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1309-1321

[46] The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].

Pitt, B ;

Zannad, F ;

Remme, WJ ;

Cody, R ;

Castaigne, A ;

Perez, A ;

Palensky, J ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717

[47] EVIDENCE THAT ANGIOTENSIN-II AND POTASSIUM COLLABORATE TO INCREASE CYTOSOLIC CALCIUM AND STIMULATE THE SECRETION OF ALDOSTERONE [J].

PRATT, JH ;

ROTHROCK, JK ;

DOMINGUEZ, JH .

ENDOCRINOLOGY, 1989, 125 (05) :2463-2469

[48] Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction [J].

Ray, KK ;

Dorman, S ;

Watson, RDS .

JOURNAL OF HUMAN HYPERTENSION, 1999, 13 (10) :717-720

[49] Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors - How much should we worry? [J].

Reardon, LC ;

Macpherson, DS .

ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (01) :26-32

[50] HYPERKALEMIA AS A COMPLICATION OF DRUG-THERAPY [J].

RIMMER, JM ;

HORN, JF ;

GENNARI, FJ .

ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (05) :867-869

← 1 2 3 4 5 6 →